HYDROCLUB 500 Capsule: Hydroxyurea IP 500 mg

Dual-Therapy Excellence: Indications in Oncology and Hematology

Mechanism of Action: Inhibitor of DNA Synthesis and HbF Booster

Addressing Chronic Myeloid Leukemia (CML) and Head & Neck Cancer

The Gold Standard for Sickle Cell Anemia (SCA) Management
Lucrative Opportunity: HYDROCLUB 500 PCD Pharma Franchise with Monopoly Rights

Hydroclub 500 Capsule

Composition : Hydroxyurea IP 500 mg Capsule

Dosage Form : Capsule

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

HYDROCLUB 500 Capsule (Hydroxyurea IP 500 mg) is a crucial oral medication that holds significant importance across two critical therapeutic areas: Oncology and Hematology. It is an antimetabolite and a potent inhibitor of ribonucleotide reductase, the enzyme essential for DNA synthesis.

Key Therapeutic Uses:

  • Oncology: It is widely used to treat Chronic Myeloid Leukemia (CML), where it helps control the proliferation of white blood cells. It is also combined with radiation therapy to manage Head and Neck Cancer (advanced squamous cell carcinoma).

  • Hematology (Sickle Cell Anemia - SCA): At lower doses, Hydroxyurea is the established standard of care for adults and children with SCA. It works by increasing the production of fetal hemoglobin (HbF), which helps to keep red blood cells round and flexible, drastically reducing the frequency of painful vaso-occlusive crises and the need for blood transfusions.

The consistent and long-term dosing required for both CML and SCA, coupled with the critical nature of these diseases, ensures a stable and high-demand market for Hydroxyurea 500 mg capsules.

We offer a high-value PCD Pharma Franchise opportunity for HYDROCLUB 500. By partnering with us, you gain Monopoly Rights in your territory, allowing you to penetrate both the specialized oncology/hematology centers and general retail channels with a product of proven efficacy and market stability.

Read More

About the Product

HYDROCLUB 500 Capsule (Hydroxyurea IP 500 mg) is a crucial oral medication that holds significant importance across two critical therapeutic areas: Oncology and Hematology. It is an antimetabolite and a potent inhibitor of ribonucleotide reductase, the enzyme essential for DNA synthesis.

Key Therapeutic Uses:

  • Oncology: It is widely used to treat Chronic Myeloid Leukemia (CML), where it helps control the proliferation of white blood cells. It is also combined with radiation therapy to manage Head and Neck Cancer (advanced squamous cell carcinoma).

  • Hematology (Sickle Cell Anemia - SCA): At lower doses, Hydroxyurea is the established standard of care for adults and children with SCA. It works by increasing the production of fetal hemoglobin (HbF), which helps to keep red blood cells round and flexible, drastically reducing the frequency of painful vaso-occlusive crises and the need for blood transfusions.

The consistent and long-term dosing required for both CML and SCA, coupled with the critical nature of these diseases, ensures a stable and high-demand market for Hydroxyurea 500 mg capsules.

We offer a high-value PCD Pharma Franchise opportunity for HYDROCLUB 500. By partnering with us, you gain Monopoly Rights in your territory, allowing you to penetrate both the specialized oncology/hematology centers and general retail channels with a product of proven efficacy and market stability.

May cause headache, muscle pain, nausea, abdominal discomfort, or mild liver enzyme elevation. Rarely, serious muscle problems (myopathy or rhabdomyolysis) may occur.

Primary hypercholesterolemia Mixed dyslipidemia Familial hypercholesterolemia Prevention of cardiovascular disease in high-risk patients

Take under medical supervision, preferably once daily, with or without food. Regular liver function and lipid profile monitoring is advised. Inform your doctor about any muscle pain, weakness, or pre-existing liver/kidney conditions. Avoid excessive alcohol intake.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch